New Releases from NCBI BookshelfDabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma.Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma.
Post Content
What Is the Reimbursement Recommendation for Trabectedin?
Canada’s Drug Agency (CDA-AMC) recommends that Nubeqa be reimbursed by public drug plans for use in combination with androgen deprivation
Global crises, such as the COVID-19 pandemic, increase the risk of perinatal depression and anxiety. A recent systematic review of
Recent reports based on the US Food and Drug Administration’s voluntary Adverse Events Reporting System raised questions about the safety
Early relationships are foundational for lifelong health, learning, and well-being. Mutual, meaningful, and affirming moments of connection in the youngest
Chiari type I malformation (CM) and syringomyelia (SM) are closely associated but incompletely understood disorders of the craniovertebral junction and